J. Maesaka

S. Fishbane, J. Maesaka, E. Flaster, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Utilizing Continuous Quality Improvement Techniques in Dialysis: Application to Anemia Management

J. Maesaka, Steven Fishbone, J. Trenkle, 1998 .

The evaluation of iron status in hemodialysis patients.

S. Fishbane, J. Maesaka, L. Imbriano, 1996, Journal of the American Society of Nephrology : JASN.

Accelerated Glucose Intolerance, Nephropathy, and Atherosclerosis in Prostaglandin D2 Synthase Knock-out Mice*

L. Ragolia, Y. Urade, J. Maesaka, 2005, Journal of Biological Chemistry.

Treating Interdialytic Hyperkalemia with Fludrocortisone

J. Maesaka, L. Imbriano, J. Durham, 2003, Seminars in dialysis.

Effect of saline infusion on phosphate transport in intact and thyroparathyroidectomized rats.

J. Maesaka, R. Abramson, M. F. Levitt, 1973, The American journal of physiology.

Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients.

S. Fishbane, J. Maesaka, E. Flaster, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of volume overload in dialysis-refractory hypertension.

S. Fishbane, J. Maesaka, E. Natke, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The role of lead in gout nephropathy.

V. Batuman, R. Wedeen, J. Maesaka, 1981, The New England journal of medicine.

Diagnosis of Iron Deficiency in End‐Stage Renal Disease

S. Fishbane, J. Maesaka, S. Mittal, 1999 .

Current Issues in Iron Management in End‐Stage Renal Disease

J. Maesaka, S. Fishbane, 2008, Seminars in dialysis.

Iron management in end-stage renal disease.

S. Fishbane, J. Maesaka, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

IN-DEPTH REVIEW Iron Management in End-Stage Renal Disease

S. Fishbane, J. Maesaka, 1997 .

Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells.

L. Ragolia, S. Fishbane, J. Maesaka, 2004, Kidney international.

Cerebral Salt-Wasting Syndrome: Does It Exist?

S. Fishbane, J. Maesaka, Sandeep Gupta, 1999, Nephron.

J. Maesaka, L. Wise, H. Thies, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Phagocytosis of E. coli by renal tubular epithelia.

J. Maesaka, T. Shimamura, 1984, The Yale journal of biology and medicine.

Dysproteinemia, proteinuria, and glomerulonephritis.

V. D’Agati, S. Nasr, J. Maesaka, 2006, Kidney international.

Evidence for renal tubular leakage in maleic acid-induced Fanconi syndrome.

J. Maesaka, M. McCaffery, 1980, The American journal of physiology.

A method to identify microinjected nephrons of rat.

J. Maesaka, T. Shimamura, 1984, Stain technology.

Is there material hazard to treatment with intravenous iron?

S. Fishbane, J. Maesaka, S. Mittal, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Effect of Recombinant Human Insulin-Like Growth Factor-I on Chronic Puromycin Aminonucleoside Nephropathy in Rats

H. Trachtman, J. Maesaka, S. Futterweit, 1996, Pediatric Research.

Contribution of prostaglandin D2 synthase to progression of renal failure and dialysis dementia.

L. Ragolia, S. Fishbane, J. Maesaka, 2002, Seminars in nephrology.

Complexity of Differentiating Cerebral-Renal Salt Wasting from SIADH, Emerging Importance of Determining Fractional Urate Excretion

S. Shirazian, J. Maesaka, L. Imbriano, 2012 .

Elevated Prostaglandin D 2 Synthase Activity Contributes to PMA-induced Apoptosis in LLC-PK 1 Cells Concomitant with Down-regulation of PI 3K

L. Ragolia, J. Maesaka, T. Palaia, 2002 .

Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease.

V. Batuman, J. Maesaka, S. Shakamuri, 1982, Archives of internal medicine.

Plasma natriuretic factor(s) in patients with intracranial disease, renal salt wasting and hyperuricosuria.

A. Dreisbach, J. Maesaka, J. Wetherington, 1993, Life sciences.

Abnormal urate transport in patients with intracranial disease.

A. Dreisbach, J. Maesaka, J. Wetherington, 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prostaglandin D2 synthase: Apoptotic factor in alzheimer plasma, inducer of reactive oxygen species, inflammatory cytokines and dialysis dementia.

L. Ragolia, M. El-Sabban, V. Batuman, 2013, Journal of nephropathology.

Beneficial effects of iron therapy in renal failure patients on hemodialysis.

S. Fishbane, J. Maesaka, S. Mittal, 1999, Kidney international. Supplement.

Elevated 1,25-Dihydroxyvitamin D Levels: Occurrence With Sarcoidosis With End-Stage Renal Disease

Shobha, V. Batuman, J. Maesaka, 1982 .

Differentiating SIADH from Cerebral/Renal Salt Wasting: Failure of the Volume Approach and Need for a New Approach to Hyponatremia

J. Maesaka, L. Imbriano, J. Mattana, 2014, Journal of clinical medicine.

Cerebral–Renal Salt Wasting

S. Shirazian, J. Maesaka, L. Imbriano, 2013 .

Contribution of lead to hypertension with renal impairment.

V. Batuman, R. Wedeen, J. Maesaka, 1983, The New England journal of medicine.

Prostaglandin D2 synthase induces apoptosis in pig kidney LLC-PK1 cells

L. Ragolia, S. Fishbane, J. Maesaka, 2001 .

Demonstration of natriuretic activity in urine of neurosurgical patients with renal salt wasting

J. Maesaka, M. Fein, S. Youmans, 2013, F1000Research.

Demonstration of natriuretic activity in urine of neurosurgical patients with renal salt wasting.

J. Maesaka, M. Fein, S. Youmans, 2013, F1000Research.

Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats.

H. Trachtman, J. Maesaka, J. Sturman, 1995, The American journal of physiology.

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.

S. Fishbane, J. Maesaka, G. Frei, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypouricemia in acquired immunodeficiency syndrome.

A. Dreisbach, J. Maesaka, A. Cusano, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients.

S. Fishbane, J. Maesaka, J. Ruggian, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Elevated L-PGDS activity contributes to PMA-induced apoptosis concomitant with downregulation of PI3-K.

Louis Ragolia, L. Ragolia, J. Maesaka, 2003, American journal of physiology. Cell physiology.

Porphyria Cutanea Tarda in a Patient on Chronic Ambulatory Peritoneal Dialysis1

J. Maesaka, C., John, 2005 .

Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.

S. Fishbane, J. Maesaka, G. Frei, 1996, Journal of the American Society of Nephrology : JASN.

Renal and electrolyte effects of total parenteral nutrition.

V. Batuman, A. Dreisbach, M. Rothkopf, 1984, JPEN. Journal of parenteral and enteral nutrition.

Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy.

J. Maesaka, S. Davis, B. Haddad, 1980, Journal of medicine.

Partial characterization of apoptotic factor in Alzheimer plasma.

M. El-Sabban, S. Fishbane, J. Maesaka, 1999, American journal of physiology. Renal physiology.

Fellows’ Forum in Dialysis   edited by Mark A. Perazella: A Patient With an Uncommon Etiology of Intradialytic Hypotension

J. Maesaka, N. Miyawaki, Naveed N. Masani, 2005, Seminars in dialysis.

Identification of a Novel Natriuretic Protein in Patients With Cerebral-Renal Salt Wasting-Implications for Enhanced Diagnosis.

W. Comper, L. M. Russo, Xiaomin Song, 2020, The American journal of the medical sciences.

Evolution and evolving resolution of controversy over existence and prevalence of cerebral/renal salt wasting.

J. Maesaka, L. Imbriano, N. Miyawaki, 2020, Current opinion in nephrology and hypertension.

Determining Fractional Urate Excretion Rates in Hyponatremic Conditions and Improved Methods to Distinguish Cerebral/Renal Salt Wasting From the Syndrome of Inappropriate Secretion of Antidiuretic Hormone

J. Maesaka, L. Imbriano, N. Miyawaki, 2018, Front. Med..

High Prevalence of Renal Salt Wasting Without Cerebral Disease as Cause of Hyponatremia in General Medical Wards

J. Maesaka, L. Imbriano, N. Miyawaki, 2018, The American journal of the medical sciences.

Application of established pathophysiologic processes brings greater clarity to diagnosis and treatment of hyponatremia

J. Maesaka, L. Imbriano, N. Miyawaki, 2017, World journal of nephrology.

Identifying Different Causes of Hyponatremia With Fractional Excretion of Uric Acid

J. Maesaka, L. Imbriano, J. Mattana, 2016, The American journal of the medical sciences.

More on renal salt wasting without cerebral disease: response to saline infusion.

S. Fishbane, J. Maesaka, L. Imbriano, 2009, Clinical journal of the American Society of Nephrology : CJASN.

The safety of intravenous iron dextran in hemodialysis patients.

S. Fishbane, J. Maesaka, J. Wish, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Is it cerebral or renal salt wasting?

J. Maesaka, L. Imbriano, E. Ilamathi, 2009, Kidney international.

Atypical Presentations

S. Shirazian, J. Maesaka, L. Imbriano, 2022, Diabetes and Kidney Disease.

Occupational lead nephropathy.

R. Wedeen, J. Maesaka, M. Joselow, 1975, The American journal of medicine.

An expanded view of SIADH, hyponatremia and hypouricemia.

J. Maesaka, 1996, Clinical nephrology.

Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.

H. Trachtman, J. Maesaka, E. Valderrama, 1995, Journal of the American Society of Nephrology : JASN.

Dietary Vitamin E Supplementation Ameliorates Renal Injury in Chronic Puromycin Aminonucleoside

Elsa, H. Trachtman, J. Maesaka, 2005 .

Atypical Presentations of Diabetic Nephropathy and Novel Therapies

G. Jerums, S. Shirazian, J. Maesaka, 2014 .

Sucralfate on Serum Lipids and Lipoproteins in Normal Volunteers

M. H. Schwenk, J. Maesaka, M. Lehrer, 1994 .

Computerized Clinical Decision Support

S. Shirazian, J. Maesaka, L. Imbriano, 2022, Diabetes and Kidney Disease.

Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia.

S. Fishbane, J. Maesaka, T. Palaia, 2007, Kidney international.

New Approach to Hyponatremia: High Prevalence of Cerebral/Renal Salt Wasting, Identification of Natriuretic Protein That Causes Salt Wasting

J. Maesaka, L. Imbriano, N. Miyawaki, 2022, Journal of clinical medicine.

Prevalence of hypertension in a hemodialysis population.

J. Maesaka, E. Flaster, E. Boylan, 1999, Clinical nephrology.

Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease.

P. Singhal, J. Maesaka, J. Mattana, 1993, American journal of nephrology.

Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.

J. Maesaka, L. Imbriano, N. Miyawaki, 2012, Journal of nephrology.

Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells.

L. Ragolia, S. Fishbane, J. Maesaka, 2001, Kidney international.

Hypouricemia, Abnormal Renal Tubular Urate Transport, and Plasma Natriuretic Factor(s) in Patients with Alzheimer's Disease

G. Wolf-Klein, J. Maesaka, Joanne M. Piccione, 1993, Journal of the American Geriatrics Society.

Cerebral Salt Wasting Is a Real Cause of Hyponatremia: PRO.

J. Maesaka, L. Imbriano, 2022, Kidney360.

J. Maesaka, L. Imbriano, N. Miyawaki, 2023, Biomolecules.

Erythropoietin and visual hallucinations in patients on dialysis.

J. Maesaka, S. Saravay, H. Steinberg, 1996, Psychosomatics.

Fructose: A New Variable to Consider in SIADH and the Hyponatremia Associated With Long-Distance Running?

M. Lanaspa, M. Kanbay, J. Maesaka, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells

L. Ragolia, S. Fishbane, J. Maesaka, 2001, Neuroreport.

Complexity of Differentiating Cerebral-Renal Salt Wasting from SIADH, Emerging Importance of Determining Fractional Urate Excretion

J. Maesaka, L. Imbriano, N. Miyawaki, 2012 .

Vascular Cases of High Output Heart Failure Masquerading as Low Output Heart Failure

J. Maesaka, L. Imbriano, 2021, Journal of Urology and Renal Diseases.

Reversible anuric acute kidney injury secondary to acute renal autoregulatory dysfunction

J. Maesaka, L. Imbriano, J. Mattana, 2014, Renal failure.

Complexity of Differentiating Cerebral-Renal Salt Wasting from SIADH, Emerging Importance of Determining Fractional Urate Excretion

J. Maesaka, L. Imbriano, N. Miyawaki, 2012 .

High prevalence of renal salt wasting induced by haptoglobin-related protein without signal peptide is linked to new syndrome of salt wasting in Alzheimer disease.

J. Maesaka, L. Imbriano, N. Miyawaki, 2023, Kidney research and clinical practice.

Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.

J. Maesaka, L. Imbriano, N. Miyawaki, 2012, Journal of nephrology.

Urine of patients with cerebral/renal salt-wasting syndrome contains a substance that inhibits reabsorptive sodium flux in LLC-PK1 cells

J. Maesaka, S. Youmans, 2011 .

The Case | A 66-year-old male with hyponatremia. Psychogenic polydipsia.

J. Maesaka, L. Imbriano, N. Ali, 2009, Kidney international.

Hyponatremia and hypouricemia: differentiation from SIADH.

V. Batuman, J. Maesaka, A. Sved, 1990, Clinical nephrology.

Paraneoplastic syndromes of the kidney.

S. Fishbane, J. Maesaka, S. Mittal, 1997, Seminars in oncology.